Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vernakalant vs Amiodarone in Recent Onset Atrial Fibrillation
NCT01627106Phase 4Withdrawn
- Sponsor
- ADVANZ PHARMA
- Start
- Sep 2012
- Primary completion
- Feb 2016
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of vernakalant in Atrial fibrillation (AFib), sponsored by ADVANZ PHARMA. Planned start Sep 2012; status: withdrawn.
02
Drugs
vernakalant
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT01627106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01627106.